- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Patent holdings for IPC class A61K 31/4184
Total number of patents in this class: 4643
10-year publication summary
|
331
|
325
|
346
|
376
|
336
|
366
|
404
|
324
|
295
|
82
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
81 |
| AstraZeneca AB | 3042 |
55 |
| Janssen Pharmaceutica N.V. | 3839 |
53 |
| The Regents of the University of California | 18943 |
51 |
| Novartis AG | 11238 |
43 |
| Merck Sharp & Dohme LLC | 3689 |
41 |
| Array BioPharma Inc. | 551 |
38 |
| The Johns Hopkins University | 5377 |
37 |
| Takeda Pharmaceutical Company Limited | 2961 |
37 |
| Immunomedics, Inc. | 290 |
36 |
| Bristol-myers Squibb Company | 5080 |
33 |
| Abbvie Inc. | 1808 |
33 |
| Gilead Sciences, Inc. | 1879 |
32 |
| Achillion Pharmaceuticals, Inc. | 176 |
29 |
| Merck Sharp & Dohme Corp. | 2247 |
27 |
| HK Inno.n Corporation | 90 |
26 |
| Boehringer Ingelheim Vetmedica GmbH | 1290 |
25 |
| Allergan, Inc. | 2600 |
25 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
25 |
| Eagle Pharmaceuticals, Inc. | 101 |
25 |
| Other owners | 3891 |